Yu Lou

4.1k total citations
131 papers, 3.2k citations indexed

About

Yu Lou is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Yu Lou has authored 131 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Infectious Diseases, 46 papers in Virology and 35 papers in Epidemiology. Recurrent topics in Yu Lou's work include HIV/AIDS drug development and treatment (73 papers), HIV Research and Treatment (46 papers) and Pneumocystis jirovecii pneumonia detection and treatment (26 papers). Yu Lou is often cited by papers focused on HIV/AIDS drug development and treatment (73 papers), HIV Research and Treatment (46 papers) and Pneumocystis jirovecii pneumonia detection and treatment (26 papers). Yu Lou collaborates with scholars based in United States, China and United Kingdom. Yu Lou's co-authors include Stephen C. Piscitelli, Daniel S. Stein, Sherene Min, Julie Borland, Ivy Song, Susan L. Ford, Brian M. Sadler, Shuguang Chen, William Spreen and Catherine Gillotin and has published in prestigious journals such as Blood, ACS Nano and PLoS ONE.

In The Last Decade

Yu Lou

126 papers receiving 3.0k citations

Peers

Countries citing papers authored by Yu Lou

Since Specialization

Citations

This map shows the geographic impact of Yu Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Lou more than expected).

Fields of papers citing papers by Yu Lou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Lou. The network helps show where Yu Lou may publish in the future.

Co-authorship network of co-authors of Yu Lou

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Lou. A scholar is included among the top collaborators of Yu Lou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Lou. Yu Lou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Unblocking the potential of Ni-based metallic glasses for glucose sensing through surface porous engineering 2025 ·Journal of Materials Chemistry A ·Lan Tan, (unknown), (unknown), Yu Lou, (unknown), (unknown), Sinan Liu, Jianrong Zeng, Zhu He, Si Lan	0
2	Elucidating the dominant role of π–π interactions in methylene blue removal via porous biochar: A synergistic approach of experimental and theoretical mechanistic insights 2025 ·Colloids and Surfaces A Physicochemical and Engineering Aspects ·Wenchao Ji, Hongyue Jin, Hongying Wang, Salma Tabassum, Yu Lou, Xingjun Fan, (unknown), Junjie Wang	6
3	Tailored Supramolecular Interface Enables Efficient and Stable Tin Halide Perovskite Photovoltaics 2025 ·ACS Energy Letters ·Miao Zeng, Zhongliang Yan, Xinyu Ye, Yu Lou, Tao Sheng, Xianyuan Jiang, Yulin Mao, Arui Huang, Xueying Yang, Zhaojin Wang, Yuanmiao Sun, Yang Bai, Hui–Ming Cheng, Guichuan Xing	9
4	HIF-1α in CD4+ T cells drives gout pathogenesis via metabolic reprogramming and Th17 differentiation 2025 ·Journal of Pharmaceutical Analysis ·(unknown), (unknown), (unknown), Kejian Shi, Yu Lou, An Xu, Yun Zhang, Chengping Wen, Tiejuan Shao	0
5	Pressure‐Tailored Energy State and Medium‐Range‐Order Structure in Fe‐Ni‐P Nanostructured Metallic Glass for High‐Sensitive Glucose Detection 2025 ·Small ·Bin Li, (unknown), Jianwu Wen, Yu Lou, Xuechun Zhou, Shuangqin Chen, Si Lan, Tao Feng	0
6	Ultrafast joule-heating synthesis of FeCoMnCuAl high-entropy-alloy nanoparticles as efficient OER electrocatalysts 2024 ·Progress in Natural Science Materials International ·(unknown), Wen Huang, Yu Lou, (unknown), (unknown), (unknown), Lan Tan, Jianrong Zeng, (unknown), He Zhu, Si Lan	17
7	Dapagliflozin Alleviates High-Fat-Induced Obesity Cardiomyopathy by Inhibiting Ferroptosis 2024 ·ESC Heart Failure ·Di Chen, Jiahao Shi, Yue Wu, (unknown), Zilin Wang, Yixuan Wang, (unknown), Yu Lou	6
8	Antifungal strains M1-8 and M6-4 as biocontrol agents against Aspergillus flavus on peanut kernels 2023 ·Quality Assurance and Safety of Crops & Foods ·Yanjie Yi, (unknown), Yu Lou, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	6
9	Surface Structure Analysis and Formaldehyde Removal Mechanism of Lotus Shell Biochar: An Experimental and Theoretical Perspective 2023 ·Langmuir ·Wenchao Ji, Manping Zhang, Xingjun Fan, Haiming Zou, (unknown), Yongbing Cai, Fande Meng, Hongying Wang, Yu Lou	5
10	Formation of strong and ductile FeNiCoCrB network-structured high-entropy alloys by fluxing 2023 ·Microstructures ·(unknown), Xiao Yang, Haiyan He, (unknown), Zheng Guo, Lifeng Wang, Jiacheng Ge, Sinan Liu, Shu Fu, Yu Lou, Lunhua He, Yang Ren, (unknown), Zhenduo Wu, Si Lan	5
11	Preliminary Safety and Efficacy of PBCAR0191, an Allogeneic 'Off-the-Shelf' CD19-Directed CAR-T for Patients with Relapsed/Refractory (R/R) CD19+ B-ALL 2021 ·Blood ·Nitin Jain, Hagop M. Kantarjian, Scott R. Solomon, Fiona He, Craig S. Sauter, Christopher R. Heery, Alan F. List, Mark Johnson, Yu Lou, Monika Vainorius, Koen van Besien, Adam J. Olszewski, Anthony S. Stein, Bijal Shah	14
12	Nesfatin-1 inhibits free fatty acid (FFA)-induced endothelial inflammation via Gfi1/NF-κB signaling 2021 ·Bioscience Biotechnology and Biochemistry ·Qingtao Meng, Qin Lu, Zhipeng Zhang, (unknown), (unknown), Yu Lou, Yuwei Wang, (unknown), (unknown)	6
13	Neohesperidin inhibits cardiac remodeling induced by Ang II in vivo and in vitro 2020 ·Biomedicine & Pharmacotherapy ·Jingsi Zhang, Xiaodan Fu, Yang Li, Hong‐xing Wen, Lijiao Zhang, (unknown), Yu Lou, Qian Yang, (unknown)	17
14	Resveratrol prevents doxorubicin-induced cardiotoxicity in H9c2 cells through the inhibition of endoplasmic reticulum stress and the activation of the Sirt1 pathway 2015 ·International Journal of Molecular Medicine ·Yu Lou, Zhen Wang, Yi Xu, Ping Zhou, Junxian Cao, Yuanshi Li, (unknown), Junfeng Sun, (unknown)	80
15	Pharmacokinetics, Safety, and Monotherapy Antiviral Activity of GSK1265744, an HIV Integrase Strand Transfer Inhibitor 2013 ·HIV Clinical Trials ·William Spreen, Sherene Min, Susan L. Ford, (unknown), Yu Lou, (unknown), Marty St. Clair, (unknown), Tamio Fujiwara	92
16	Metamorphic evolution of high-pressure eclogite from Hong'an.Western Dabie Orogen,central China:Evidence from petrography and calculated phase equilibria in system Na_2O-CaO-K_2O-FeO-MgO-Al_2O_3-SiO_2-H_2O-O(Fe_2O_3) 2009 ·Acta Petrologica Sinica ·Yu Lou	2
17	Spectrophotometric Determination of Trace Cadmium in Environmental Water Samples 2003 ·Chinese Journal of Spectroscopy Laboratory ·Yu Lou, (unknown)	1
18	Application and Discussion on floor arch board technology in project with water inrush and swelling soft rock 2003 ·Coal science and technology ·Yu Lou	1
19	Metabolic Disposition and Pharmacokinetics of [¹⁴C]‐Amprenavir, a Human Immunodeficiency Virus Type 1 (HIV‐1) Protease Inhibitor, Administered As a Single Oral Dose to Healthy Male Subjects 2001 ·The Journal of Clinical Pharmacology ·Brian M. Sadler, Gregory E. Chittick, Ronald E. Polk, Douglas Slain, Thomas M. Kerkering, Scott D. Studenberg, Yu Lou, Katy H. P. Moore, Joseph L. Woolley, Daniel S. Stein	16
20	Pulmonary Function Tests in HIV-Infected Patients Without AIDS. Pulmonary Complications of HIV Infection Study Group 1995 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Yu Lou, (unknown), (unknown), (unknown), Albert Miller, (unknown), Lee B. Reichman, (unknown), P C Hopewell	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact